BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $680,943 | -48.6% | 18,043 | -38.0% | 0.02% | -27.3% |
| Q2 2023 | $1,325,978 | +19.6% | 29,104 | +6.5% | 0.02% | 0.0% |
| Q1 2023 | $1,108,343 | -17.4% | 27,326 | +3.8% | 0.02% | -24.1% |
| Q4 2022 | $1,341,428 | -15.0% | 26,318 | -10.3% | 0.03% | -9.4% |
| Q3 2022 | $1,579,000 | -11.2% | 29,326 | +5.9% | 0.03% | -8.6% |
| Q2 2022 | $1,779,000 | -49.3% | 27,698 | -38.7% | 0.04% | -25.5% |
| Q1 2022 | $3,506,000 | -3.9% | 45,210 | +6.4% | 0.05% | +2.2% |
| Q4 2021 | $3,647,000 | +6.2% | 42,487 | -0.5% | 0.05% | -4.2% |
| Q3 2021 | $3,433,000 | +2.5% | 42,689 | +2.6% | 0.05% | 0.0% |
| Q2 2021 | $3,349,000 | -5.5% | 41,608 | -1.0% | 0.05% | -2.0% |
| Q1 2021 | $3,543,000 | +5.6% | 42,013 | +0.5% | 0.05% | +2.1% |
| Q4 2020 | $3,355,000 | -1.8% | 41,807 | -1.6% | 0.05% | -11.1% |
| Q3 2020 | $3,415,000 | -5.9% | 42,470 | +0.8% | 0.05% | -12.9% |
| Q2 2020 | $3,628,000 | +4.6% | 42,140 | -1.4% | 0.06% | -8.8% |
| Q1 2020 | $3,469,000 | -38.6% | 42,724 | -36.8% | 0.07% | -8.1% |
| Q4 2019 | $5,652,000 | -12.4% | 67,589 | -8.4% | 0.07% | -18.7% |
| Q3 2019 | $6,455,000 | +17.8% | 73,800 | +10.3% | 0.09% | +8.3% |
| Q2 2019 | $5,478,000 | -25.5% | 66,886 | -26.1% | 0.08% | -10.6% |
| Q1 2019 | $7,356,000 | +23.3% | 90,469 | -0.2% | 0.09% | +13.3% |
| Q4 2018 | $5,967,000 | +21.1% | 90,660 | +41.9% | 0.08% | +23.9% |
| Q3 2018 | $4,927,000 | +19.6% | 63,907 | +14.5% | 0.07% | +9.8% |
| Q2 2018 | $4,121,000 | +39.1% | 55,815 | +22.6% | 0.06% | +22.0% |
| Q1 2018 | $2,962,000 | +14.3% | 45,534 | +13.6% | 0.05% | +11.1% |
| Q4 2017 | $2,591,000 | +10.7% | 40,080 | +7.4% | 0.04% | 0.0% |
| Q3 2017 | $2,341,000 | +14.3% | 37,312 | +10.2% | 0.04% | +7.1% |
| Q2 2017 | $2,049,000 | +25.1% | 33,848 | +7.2% | 0.04% | +20.0% |
| Q1 2017 | $1,638,000 | +24.4% | 31,586 | +6.4% | 0.04% | +12.9% |
| Q4 2016 | $1,317,000 | +5.6% | 29,697 | +13.3% | 0.03% | +3.3% |
| Q3 2016 | $1,247,000 | -4.8% | 26,206 | -9.5% | 0.03% | -6.2% |
| Q2 2016 | $1,310,000 | +13.4% | 28,968 | +3.0% | 0.03% | +14.3% |
| Q1 2016 | $1,155,000 | +18.5% | 28,117 | +10.0% | 0.03% | +12.0% |
| Q4 2015 | $975,000 | -4.9% | 25,557 | -18.1% | 0.02% | -7.4% |
| Q3 2015 | $1,025,000 | -74.8% | 31,211 | -46.3% | 0.03% | -74.0% |
| Q2 2015 | $4,064,000 | +0.1% | 58,111 | -2.0% | 0.10% | +6.1% |
| Q1 2015 | $4,060,000 | -7.2% | 59,271 | -0.7% | 0.10% | -8.4% |
| Q4 2014 | $4,375,000 | +23.6% | 59,696 | +21.0% | 0.11% | +5.9% |
| Q3 2014 | $3,540,000 | +2.3% | 49,330 | +3.0% | 0.10% | -1.0% |
| Q2 2014 | $3,462,000 | -12.4% | 47,882 | -10.9% | 0.10% | -8.9% |
| Q1 2014 | $3,953,000 | +10.0% | 53,722 | +3.9% | 0.11% | +15.5% |
| Q4 2013 | $3,595,000 | +5.4% | 51,691 | -0.4% | 0.10% | -1.0% |
| Q3 2013 | $3,410,000 | -1.8% | 51,915 | +3.6% | 0.10% | -6.7% |
| Q2 2013 | $3,472,000 | – | 50,128 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |